In 1985, a young New Zealander named Emily Green traveled to the renowned Karolinska Institutet in Sweden to pursue her Ph.D. in Biochemistry. It was there that she met Hans van der Berg, a brilliant student from the Netherlands also pursuing his Ph.D. in Medicine. Their shared intellect and genuine spirits drew them together, and their love story began within the halls of academia.
After graduating, Hans made a life-changing decision: he chose to follow Emily back to New Zealand. They married in a warm, intimate ceremony and began to build their new life together.
However, their happiness was soon shadowed by a significant challenge. Emily had long suffered from Polycystic Ovary Syndrome (PCOS), which brought daily discomforts and emotional struggles, in addition to making it difficult to start a family. Watching his wife endure this pain, Hans was heartbroken. As both her husband and a doctor, he vowed to use his professional expertise to help her.
For Emily's sake, Hans dedicated himself to finding a solution. He collaborated with his former Ph.D. supervisor and classmates from the Karolinska Institutet, poring over thousands of medical papers and clinical cases. After countless experiments and rigorous validations, a unique formula specifically for PCOS patients was born. It was not just a medical breakthrough but a testament to Hans's profound love. Thanks to this heartfelt formulation, Emily's health miraculously recovered, and in 1995, they welcomed their first child.
This success made Hans realize that countless other women were likely suffering from PCOS. He committed to extensive clinical validation to ensure the formula's safety and efficacy. Nearly a decade later, in 2005, as he and Emily welcomed their second baby, the Hendrick product—a blend of love and science—was officially launched.
Built on a foundation of solid medical literature and clinical data, the Hendrick product delivered outstanding and consistent results. It quickly spread through word-of-mouth among women with PCOS, becoming a trusted and preferred choice.
Hendrick Research